Furthermore, combined expression of MYC/PIK3CAE545K and MEK1DD or ER-KRASG12V in not only late-passage but also early-passage HCK1T/16epi cells gave rise to highly potent tumor-initiating cells (S1 Table). Here, MYC is linked to neoplasm.